nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ABCB1—Mitomycin—urinary bladder cancer	0.126	0.226	CbGbCtD
Propafenone—CYP3A4—Thiotepa—urinary bladder cancer	0.0574	0.103	CbGbCtD
Propafenone—CYP2C8—Fluorouracil—urinary bladder cancer	0.046	0.0822	CbGbCtD
Propafenone—CYP2C8—Etoposide—urinary bladder cancer	0.0384	0.0686	CbGbCtD
Propafenone—ABCB1—Gemcitabine—urinary bladder cancer	0.0364	0.065	CbGbCtD
Propafenone—CYP1A2—Fluorouracil—urinary bladder cancer	0.0356	0.0636	CbGbCtD
Propafenone—CYP2C9—Fluorouracil—urinary bladder cancer	0.0321	0.0573	CbGbCtD
Propafenone—CYP1A2—Etoposide—urinary bladder cancer	0.0297	0.0531	CbGbCtD
Propafenone—CYP2C9—Cisplatin—urinary bladder cancer	0.0272	0.0487	CbGbCtD
Propafenone—ABCB1—Cisplatin—urinary bladder cancer	0.0264	0.0473	CbGbCtD
Propafenone—ABCB1—Etoposide—urinary bladder cancer	0.026	0.0464	CbGbCtD
Propafenone—ABCB1—Doxorubicin—urinary bladder cancer	0.0177	0.0317	CbGbCtD
Propafenone—ABCB1—Methotrexate—urinary bladder cancer	0.0172	0.0307	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—urinary bladder cancer	0.0167	0.0298	CbGbCtD
Propafenone—CYP3A4—Etoposide—urinary bladder cancer	0.0156	0.0278	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—urinary bladder cancer	0.0106	0.019	CbGbCtD
Propafenone—CYP1A2—urine—urinary bladder cancer	0.0038	0.109	CbGeAlD
Propafenone—CYP2C9—urine—urinary bladder cancer	0.00361	0.103	CbGeAlD
Propafenone—CYP3A4—urine—urinary bladder cancer	0.00275	0.0789	CbGeAlD
Propafenone—CYP2D6—urine—urinary bladder cancer	0.00271	0.0776	CbGeAlD
Propafenone—ADRB1—prostate gland—urinary bladder cancer	0.00209	0.0598	CbGeAlD
Propafenone—Benzphetamine—POR—urinary bladder cancer	0.00206	0.43	CrCbGaD
Propafenone—KCNH2—prostate gland—urinary bladder cancer	0.00159	0.0457	CbGeAlD
Propafenone—Benazepril—MTHFR—urinary bladder cancer	0.0015	0.313	CrCbGaD
Propafenone—KCNH2—seminal vesicle—urinary bladder cancer	0.00135	0.0386	CbGeAlD
Propafenone—SCN5A—vagina—urinary bladder cancer	0.00128	0.0367	CbGeAlD
Propafenone—ADRB1—female reproductive system—urinary bladder cancer	0.00114	0.0327	CbGeAlD
Propafenone—KCNH2—renal system—urinary bladder cancer	0.00109	0.0311	CbGeAlD
Propafenone—KCNH2—urethra—urinary bladder cancer	0.00107	0.0306	CbGeAlD
Propafenone—CYP2C8—renal system—urinary bladder cancer	0.000993	0.0285	CbGeAlD
Propafenone—CYP1A2—renal system—urinary bladder cancer	0.00093	0.0267	CbGeAlD
Propafenone—KCNH2—female reproductive system—urinary bladder cancer	0.00087	0.0249	CbGeAlD
Propafenone—CYP2C8—female reproductive system—urinary bladder cancer	0.000796	0.0228	CbGeAlD
Propafenone—KCNH2—vagina—urinary bladder cancer	0.000787	0.0226	CbGeAlD
Propafenone—CYP2C8—vagina—urinary bladder cancer	0.00072	0.0206	CbGeAlD
Propafenone—CYP2C9—female reproductive system—urinary bladder cancer	0.000707	0.0203	CbGeAlD
Propafenone—ABCB1—prostate gland—urinary bladder cancer	0.000699	0.02	CbGeAlD
Propafenone—CYP3A4—renal system—urinary bladder cancer	0.000673	0.0193	CbGeAlD
Propafenone—CYP2D6—renal system—urinary bladder cancer	0.000662	0.019	CbGeAlD
Propafenone—Salsalate—PTGS2—urinary bladder cancer	0.000617	0.129	CrCbGaD
Propafenone—Oxaprozin—PTGS2—urinary bladder cancer	0.000617	0.129	CrCbGaD
Propafenone—ABCB1—seminal vesicle—urinary bladder cancer	0.000591	0.017	CbGeAlD
Propafenone—CYP3A4—female reproductive system—urinary bladder cancer	0.000539	0.0155	CbGeAlD
Propafenone—CYP2D6—female reproductive system—urinary bladder cancer	0.00053	0.0152	CbGeAlD
Propafenone—ABCB1—epithelium—urinary bladder cancer	0.000514	0.0147	CbGeAlD
Propafenone—KCNH2—lymph node—urinary bladder cancer	0.000509	0.0146	CbGeAlD
Propafenone—ABCB1—renal system—urinary bladder cancer	0.000476	0.0137	CbGeAlD
Propafenone—ABCB1—urethra—urinary bladder cancer	0.000468	0.0134	CbGeAlD
Propafenone—ABCB1—female reproductive system—urinary bladder cancer	0.000381	0.0109	CbGeAlD
Propafenone—ABCB1—vagina—urinary bladder cancer	0.000345	0.0099	CbGeAlD
Propafenone—ABCB1—lymph node—urinary bladder cancer	0.000223	0.0064	CbGeAlD
Propafenone—Body temperature increased—Etoposide—urinary bladder cancer	0.000165	0.000522	CcSEcCtD
Propafenone—Haemorrhage—Epirubicin—urinary bladder cancer	0.000165	0.000521	CcSEcCtD
Propafenone—Hepatitis—Epirubicin—urinary bladder cancer	0.000165	0.000521	CcSEcCtD
Propafenone—Eye disorder—Methotrexate—urinary bladder cancer	0.000165	0.00052	CcSEcCtD
Propafenone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000165	0.00052	CcSEcCtD
Propafenone—Tinnitus—Methotrexate—urinary bladder cancer	0.000164	0.000519	CcSEcCtD
Propafenone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000164	0.000518	CcSEcCtD
Propafenone—Asthenia—Cisplatin—urinary bladder cancer	0.000164	0.000517	CcSEcCtD
Propafenone—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000164	0.000516	CcSEcCtD
Propafenone—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000163	0.000514	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—urinary bladder cancer	0.000162	0.000512	CcSEcCtD
Propafenone—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000162	0.000512	CcSEcCtD
Propafenone—Urethral disorder—Epirubicin—urinary bladder cancer	0.000162	0.00051	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000161	0.000507	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—urinary bladder cancer	0.00016	0.000506	CcSEcCtD
Propafenone—Angiopathy—Methotrexate—urinary bladder cancer	0.00016	0.000505	CcSEcCtD
Propafenone—Immune system disorder—Methotrexate—urinary bladder cancer	0.000159	0.000502	CcSEcCtD
Propafenone—Dizziness—Fluorouracil—urinary bladder cancer	0.000159	0.000502	CcSEcCtD
Propafenone—Visual impairment—Epirubicin—urinary bladder cancer	0.000159	0.000502	CcSEcCtD
Propafenone—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000159	0.000501	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000159	0.000501	CcSEcCtD
Propafenone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000156	0.000493	CcSEcCtD
Propafenone—Alopecia—Methotrexate—urinary bladder cancer	0.000156	0.000492	CcSEcCtD
Propafenone—Vomiting—Gemcitabine—urinary bladder cancer	0.000156	0.000491	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—urinary bladder cancer	0.000155	0.00049	CcSEcCtD
Propafenone—Mental disorder—Methotrexate—urinary bladder cancer	0.000155	0.000487	CcSEcCtD
Propafenone—Rash—Gemcitabine—urinary bladder cancer	0.000154	0.000487	CcSEcCtD
Propafenone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000154	0.000487	CcSEcCtD
Propafenone—Eye disorder—Epirubicin—urinary bladder cancer	0.000154	0.000486	CcSEcCtD
Propafenone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000154	0.000486	CcSEcCtD
Propafenone—Tinnitus—Epirubicin—urinary bladder cancer	0.000154	0.000485	CcSEcCtD
Propafenone—Erythema—Methotrexate—urinary bladder cancer	0.000154	0.000484	CcSEcCtD
Propafenone—Malnutrition—Methotrexate—urinary bladder cancer	0.000154	0.000484	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000153	0.000484	CcSEcCtD
Propafenone—Headache—Gemcitabine—urinary bladder cancer	0.000153	0.000484	CcSEcCtD
Propafenone—Flushing—Epirubicin—urinary bladder cancer	0.000153	0.000483	CcSEcCtD
Propafenone—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000153	0.000483	CcSEcCtD
Propafenone—Vomiting—Fluorouracil—urinary bladder cancer	0.000153	0.000483	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—urinary bladder cancer	0.000153	0.000483	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—urinary bladder cancer	0.000153	0.000482	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000153	0.000482	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000152	0.000479	CcSEcCtD
Propafenone—Rash—Fluorouracil—urinary bladder cancer	0.000152	0.000479	CcSEcCtD
Propafenone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000152	0.000479	CcSEcCtD
Propafenone—Headache—Fluorouracil—urinary bladder cancer	0.000151	0.000476	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000151	0.000476	CcSEcCtD
Propafenone—Dysgeusia—Methotrexate—urinary bladder cancer	0.00015	0.000474	CcSEcCtD
Propafenone—Asthenia—Etoposide—urinary bladder cancer	0.00015	0.000473	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00015	0.000473	CcSEcCtD
Propafenone—Angiopathy—Epirubicin—urinary bladder cancer	0.00015	0.000472	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00015	0.000472	CcSEcCtD
Propafenone—Immune system disorder—Epirubicin—urinary bladder cancer	0.000149	0.00047	CcSEcCtD
Propafenone—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000149	0.000469	CcSEcCtD
Propafenone—Pruritus—Etoposide—urinary bladder cancer	0.000148	0.000467	CcSEcCtD
Propafenone—Arrhythmia—Epirubicin—urinary bladder cancer	0.000147	0.000465	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—urinary bladder cancer	0.000147	0.000464	CcSEcCtD
Propafenone—Alopecia—Epirubicin—urinary bladder cancer	0.000146	0.00046	CcSEcCtD
Propafenone—Nausea—Gemcitabine—urinary bladder cancer	0.000146	0.000459	CcSEcCtD
Propafenone—Vomiting—Cisplatin—urinary bladder cancer	0.000145	0.000458	CcSEcCtD
Propafenone—Vision blurred—Methotrexate—urinary bladder cancer	0.000145	0.000456	CcSEcCtD
Propafenone—Mental disorder—Epirubicin—urinary bladder cancer	0.000145	0.000456	CcSEcCtD
Propafenone—Rash—Cisplatin—urinary bladder cancer	0.000144	0.000454	CcSEcCtD
Propafenone—Dermatitis—Cisplatin—urinary bladder cancer	0.000144	0.000454	CcSEcCtD
Propafenone—Malnutrition—Epirubicin—urinary bladder cancer	0.000144	0.000453	CcSEcCtD
Propafenone—Erythema—Epirubicin—urinary bladder cancer	0.000144	0.000453	CcSEcCtD
Propafenone—Diarrhoea—Etoposide—urinary bladder cancer	0.000143	0.000451	CcSEcCtD
Propafenone—Nausea—Fluorouracil—urinary bladder cancer	0.000143	0.000451	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—urinary bladder cancer	0.000143	0.00045	CcSEcCtD
Propafenone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000142	0.000449	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—urinary bladder cancer	0.000142	0.000449	CcSEcCtD
Propafenone—Anaemia—Methotrexate—urinary bladder cancer	0.000142	0.000448	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000142	0.000447	CcSEcCtD
Propafenone—Flushing—Doxorubicin—urinary bladder cancer	0.000142	0.000447	CcSEcCtD
Propafenone—Flatulence—Epirubicin—urinary bladder cancer	0.000142	0.000447	CcSEcCtD
Propafenone—Tension—Epirubicin—urinary bladder cancer	0.000141	0.000445	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—urinary bladder cancer	0.000141	0.000444	CcSEcCtD
Propafenone—Nervousness—Epirubicin—urinary bladder cancer	0.00014	0.00044	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—urinary bladder cancer	0.000139	0.000437	CcSEcCtD
Propafenone—Malaise—Methotrexate—urinary bladder cancer	0.000138	0.000437	CcSEcCtD
Propafenone—Dizziness—Etoposide—urinary bladder cancer	0.000138	0.000436	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000138	0.000436	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000138	0.000435	CcSEcCtD
Propafenone—Vertigo—Methotrexate—urinary bladder cancer	0.000138	0.000435	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000138	0.000434	CcSEcCtD
Propafenone—Leukopenia—Methotrexate—urinary bladder cancer	0.000137	0.000433	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000136	0.00043	CcSEcCtD
Propafenone—Nausea—Cisplatin—urinary bladder cancer	0.000136	0.000428	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—urinary bladder cancer	0.000135	0.000427	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—urinary bladder cancer	0.000135	0.000426	CcSEcCtD
Propafenone—Cough—Methotrexate—urinary bladder cancer	0.000134	0.000423	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—urinary bladder cancer	0.000134	0.000422	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000133	0.00042	CcSEcCtD
Propafenone—Convulsion—Methotrexate—urinary bladder cancer	0.000133	0.00042	CcSEcCtD
Propafenone—Vomiting—Etoposide—urinary bladder cancer	0.000133	0.000419	CcSEcCtD
Propafenone—Erythema—Doxorubicin—urinary bladder cancer	0.000133	0.000419	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—urinary bladder cancer	0.000133	0.000419	CcSEcCtD
Propafenone—Anaemia—Epirubicin—urinary bladder cancer	0.000133	0.000419	CcSEcCtD
Propafenone—Rash—Etoposide—urinary bladder cancer	0.000132	0.000416	CcSEcCtD
Propafenone—Dermatitis—Etoposide—urinary bladder cancer	0.000132	0.000416	CcSEcCtD
Propafenone—Headache—Etoposide—urinary bladder cancer	0.000131	0.000413	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—urinary bladder cancer	0.000131	0.000413	CcSEcCtD
Propafenone—Chest pain—Methotrexate—urinary bladder cancer	0.000131	0.000412	CcSEcCtD
Propafenone—Myalgia—Methotrexate—urinary bladder cancer	0.000131	0.000412	CcSEcCtD
Propafenone—Tension—Doxorubicin—urinary bladder cancer	0.00013	0.000411	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00013	0.000411	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00013	0.000409	CcSEcCtD
Propafenone—Malaise—Epirubicin—urinary bladder cancer	0.00013	0.000409	CcSEcCtD
Propafenone—Discomfort—Methotrexate—urinary bladder cancer	0.000129	0.000407	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—urinary bladder cancer	0.000129	0.000407	CcSEcCtD
Propafenone—Vertigo—Epirubicin—urinary bladder cancer	0.000129	0.000407	CcSEcCtD
Propafenone—Syncope—Epirubicin—urinary bladder cancer	0.000129	0.000406	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—urinary bladder cancer	0.000129	0.000406	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000128	0.000403	CcSEcCtD
Propafenone—Palpitations—Epirubicin—urinary bladder cancer	0.000127	0.0004	CcSEcCtD
Propafenone—Confusional state—Methotrexate—urinary bladder cancer	0.000126	0.000398	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000126	0.000398	CcSEcCtD
Propafenone—Cough—Epirubicin—urinary bladder cancer	0.000125	0.000395	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—urinary bladder cancer	0.000125	0.000395	CcSEcCtD
Propafenone—Convulsion—Epirubicin—urinary bladder cancer	0.000124	0.000393	CcSEcCtD
Propafenone—Infection—Methotrexate—urinary bladder cancer	0.000124	0.000393	CcSEcCtD
Propafenone—Nausea—Etoposide—urinary bladder cancer	0.000124	0.000392	CcSEcCtD
Propafenone—Hypertension—Epirubicin—urinary bladder cancer	0.000124	0.000391	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000123	0.000389	CcSEcCtD
Propafenone—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000123	0.000388	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—urinary bladder cancer	0.000123	0.000388	CcSEcCtD
Propafenone—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000123	0.000387	CcSEcCtD
Propafenone—Chest pain—Epirubicin—urinary bladder cancer	0.000122	0.000386	CcSEcCtD
Propafenone—Myalgia—Epirubicin—urinary bladder cancer	0.000122	0.000386	CcSEcCtD
Propafenone—Anxiety—Epirubicin—urinary bladder cancer	0.000122	0.000384	CcSEcCtD
Propafenone—Skin disorder—Methotrexate—urinary bladder cancer	0.000122	0.000384	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000121	0.000383	CcSEcCtD
Propafenone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000121	0.000382	CcSEcCtD
Propafenone—Discomfort—Epirubicin—urinary bladder cancer	0.000121	0.000381	CcSEcCtD
Propafenone—Malaise—Doxorubicin—urinary bladder cancer	0.00012	0.000378	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—urinary bladder cancer	0.00012	0.000377	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—urinary bladder cancer	0.000119	0.000377	CcSEcCtD
Propafenone—Anorexia—Methotrexate—urinary bladder cancer	0.000119	0.000377	CcSEcCtD
Propafenone—Syncope—Doxorubicin—urinary bladder cancer	0.000119	0.000376	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—urinary bladder cancer	0.000119	0.000375	CcSEcCtD
Propafenone—Confusional state—Epirubicin—urinary bladder cancer	0.000118	0.000373	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—urinary bladder cancer	0.000117	0.000371	CcSEcCtD
Propafenone—Oedema—Epirubicin—urinary bladder cancer	0.000117	0.00037	CcSEcCtD
Propafenone—Hypotension—Methotrexate—urinary bladder cancer	0.000117	0.000369	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000117	0.000369	CcSEcCtD
Propafenone—Infection—Epirubicin—urinary bladder cancer	0.000116	0.000367	CcSEcCtD
Propafenone—Cough—Doxorubicin—urinary bladder cancer	0.000116	0.000366	CcSEcCtD
Propafenone—Shock—Epirubicin—urinary bladder cancer	0.000115	0.000364	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—urinary bladder cancer	0.000115	0.000363	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000115	0.000363	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000115	0.000362	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—urinary bladder cancer	0.000115	0.000362	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—urinary bladder cancer	0.000114	0.000361	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000114	0.00036	CcSEcCtD
Propafenone—Skin disorder—Epirubicin—urinary bladder cancer	0.000114	0.000359	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000113	0.000358	CcSEcCtD
Propafenone—Insomnia—Methotrexate—urinary bladder cancer	0.000113	0.000357	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—urinary bladder cancer	0.000113	0.000357	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—urinary bladder cancer	0.000113	0.000357	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—urinary bladder cancer	0.000113	0.000356	CcSEcCtD
Propafenone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000113	0.000355	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000112	0.000355	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—urinary bladder cancer	0.000112	0.000353	CcSEcCtD
Propafenone—Anorexia—Epirubicin—urinary bladder cancer	0.000112	0.000353	CcSEcCtD
Propafenone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000112	0.000352	CcSEcCtD
Propafenone—Somnolence—Methotrexate—urinary bladder cancer	0.000111	0.000351	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000111	0.000349	CcSEcCtD
Propafenone—Dyspepsia—Methotrexate—urinary bladder cancer	0.00011	0.000348	CcSEcCtD
Propafenone—Hypotension—Epirubicin—urinary bladder cancer	0.00011	0.000346	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—urinary bladder cancer	0.000109	0.000345	CcSEcCtD
Propafenone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000109	0.000344	CcSEcCtD
Propafenone—Oedema—Doxorubicin—urinary bladder cancer	0.000108	0.000342	CcSEcCtD
Propafenone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000108	0.000341	CcSEcCtD
Propafenone—Fatigue—Methotrexate—urinary bladder cancer	0.000108	0.000341	CcSEcCtD
Propafenone—Infection—Doxorubicin—urinary bladder cancer	0.000108	0.00034	CcSEcCtD
Propafenone—Pain—Methotrexate—urinary bladder cancer	0.000107	0.000338	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000107	0.000337	CcSEcCtD
Propafenone—Shock—Doxorubicin—urinary bladder cancer	0.000107	0.000337	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000106	0.000336	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000106	0.000335	CcSEcCtD
Propafenone—Insomnia—Epirubicin—urinary bladder cancer	0.000106	0.000334	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000106	0.000334	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—urinary bladder cancer	0.000105	0.000332	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000105	0.000332	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000105	0.000331	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—urinary bladder cancer	0.000105	0.00033	CcSEcCtD
Propafenone—Somnolence—Epirubicin—urinary bladder cancer	0.000104	0.000329	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—urinary bladder cancer	0.000103	0.000326	CcSEcCtD
Propafenone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000103	0.000326	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000103	0.000326	CcSEcCtD
Propafenone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000102	0.000323	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000102	0.000321	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—urinary bladder cancer	0.000101	0.00032	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000101	0.000319	CcSEcCtD
Propafenone—Fatigue—Epirubicin—urinary bladder cancer	0.000101	0.000319	CcSEcCtD
Propafenone—Constipation—Epirubicin—urinary bladder cancer	0.0001	0.000316	CcSEcCtD
Propafenone—Pain—Epirubicin—urinary bladder cancer	0.0001	0.000316	CcSEcCtD
Propafenone—Urticaria—Methotrexate—urinary bladder cancer	9.95e-05	0.000314	CcSEcCtD
Propafenone—Body temperature increased—Methotrexate—urinary bladder cancer	9.9e-05	0.000312	CcSEcCtD
Propafenone—Abdominal pain—Methotrexate—urinary bladder cancer	9.9e-05	0.000312	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	9.88e-05	0.000312	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—urinary bladder cancer	9.81e-05	0.000309	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—urinary bladder cancer	9.74e-05	0.000307	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—urinary bladder cancer	9.67e-05	0.000305	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—urinary bladder cancer	9.66e-05	0.000305	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—urinary bladder cancer	9.64e-05	0.000304	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	9.59e-05	0.000302	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—urinary bladder cancer	9.55e-05	0.000301	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—urinary bladder cancer	9.43e-05	0.000297	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	9.37e-05	0.000295	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—urinary bladder cancer	9.35e-05	0.000295	CcSEcCtD
Propafenone—Urticaria—Epirubicin—urinary bladder cancer	9.31e-05	0.000294	CcSEcCtD
Propafenone—Pain—Doxorubicin—urinary bladder cancer	9.28e-05	0.000293	CcSEcCtD
Propafenone—Constipation—Doxorubicin—urinary bladder cancer	9.28e-05	0.000293	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—urinary bladder cancer	9.27e-05	0.000292	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—urinary bladder cancer	9.27e-05	0.000292	CcSEcCtD
Propafenone—Hypersensitivity—Methotrexate—urinary bladder cancer	9.23e-05	0.000291	CcSEcCtD
Propafenone—Asthenia—Methotrexate—urinary bladder cancer	8.99e-05	0.000284	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—urinary bladder cancer	8.94e-05	0.000282	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	8.87e-05	0.00028	CcSEcCtD
Propafenone—Pruritus—Methotrexate—urinary bladder cancer	8.86e-05	0.00028	CcSEcCtD
Propafenone—Hypersensitivity—Epirubicin—urinary bladder cancer	8.64e-05	0.000272	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—urinary bladder cancer	8.62e-05	0.000272	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—urinary bladder cancer	8.58e-05	0.000271	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—urinary bladder cancer	8.58e-05	0.000271	CcSEcCtD
Propafenone—Diarrhoea—Methotrexate—urinary bladder cancer	8.57e-05	0.00027	CcSEcCtD
Propafenone—Asthenia—Epirubicin—urinary bladder cancer	8.41e-05	0.000265	CcSEcCtD
Propafenone—Pruritus—Epirubicin—urinary bladder cancer	8.3e-05	0.000262	CcSEcCtD
Propafenone—Dizziness—Methotrexate—urinary bladder cancer	8.29e-05	0.000261	CcSEcCtD
Propafenone—Diarrhoea—Epirubicin—urinary bladder cancer	8.02e-05	0.000253	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.99e-05	0.000252	CcSEcCtD
Propafenone—Vomiting—Methotrexate—urinary bladder cancer	7.97e-05	0.000251	CcSEcCtD
Propafenone—Rash—Methotrexate—urinary bladder cancer	7.9e-05	0.000249	CcSEcCtD
Propafenone—Dermatitis—Methotrexate—urinary bladder cancer	7.89e-05	0.000249	CcSEcCtD
Propafenone—Headache—Methotrexate—urinary bladder cancer	7.85e-05	0.000248	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—urinary bladder cancer	7.78e-05	0.000246	CcSEcCtD
Propafenone—Dizziness—Epirubicin—urinary bladder cancer	7.75e-05	0.000245	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—urinary bladder cancer	7.68e-05	0.000242	CcSEcCtD
Propafenone—Vomiting—Epirubicin—urinary bladder cancer	7.46e-05	0.000235	CcSEcCtD
Propafenone—Nausea—Methotrexate—urinary bladder cancer	7.44e-05	0.000235	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—urinary bladder cancer	7.42e-05	0.000234	CcSEcCtD
Propafenone—Rash—Epirubicin—urinary bladder cancer	7.39e-05	0.000233	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—urinary bladder cancer	7.39e-05	0.000233	CcSEcCtD
Propafenone—Headache—Epirubicin—urinary bladder cancer	7.35e-05	0.000232	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—urinary bladder cancer	7.17e-05	0.000226	CcSEcCtD
Propafenone—Nausea—Epirubicin—urinary bladder cancer	6.96e-05	0.00022	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—urinary bladder cancer	6.9e-05	0.000218	CcSEcCtD
Propafenone—Rash—Doxorubicin—urinary bladder cancer	6.84e-05	0.000216	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—urinary bladder cancer	6.83e-05	0.000216	CcSEcCtD
Propafenone—Headache—Doxorubicin—urinary bladder cancer	6.8e-05	0.000214	CcSEcCtD
Propafenone—Nausea—Doxorubicin—urinary bladder cancer	6.44e-05	0.000203	CcSEcCtD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.87e-05	0.000696	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.84e-05	0.000693	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	5.84e-05	0.000693	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NAT1—urinary bladder cancer	5.84e-05	0.000693	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.82e-05	0.00069	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.75e-05	0.000682	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	5.71e-05	0.000678	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—KRAS—urinary bladder cancer	5.54e-05	0.000658	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.4e-05	0.000641	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	5.37e-05	0.000637	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	5.34e-05	0.000634	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.33e-05	0.000632	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	5.25e-05	0.000623	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	5.18e-05	0.000615	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—HRAS—urinary bladder cancer	5.15e-05	0.000611	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.1e-05	0.000605	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.09e-05	0.000604	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.09e-05	0.000604	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	5.06e-05	0.0006	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.04e-05	0.000597	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	5.02e-05	0.000595	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.96e-05	0.000589	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GLI1—urinary bladder cancer	4.96e-05	0.000588	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—EP300—urinary bladder cancer	4.91e-05	0.000583	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.89e-05	0.000581	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	4.81e-05	0.000571	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	4.8e-05	0.000569	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NAT1—urinary bladder cancer	4.8e-05	0.000569	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—SRC—urinary bladder cancer	4.78e-05	0.000567	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.75e-05	0.000564	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.75e-05	0.000564	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—HRAS—urinary bladder cancer	4.71e-05	0.000559	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.68e-05	0.000555	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.66e-05	0.000552	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	4.54e-05	0.000539	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	4.43e-05	0.000525	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	4.39e-05	0.00052	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.35e-05	0.000516	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.33e-05	0.000513	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.29e-05	0.000509	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.27e-05	0.000507	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.19e-05	0.000497	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	4.19e-05	0.000497	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.18e-05	0.000495	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.06e-05	0.000482	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.06e-05	0.000482	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4e-05	0.000474	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CXCL8—urinary bladder cancer	4e-05	0.000474	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TNF—urinary bladder cancer	3.99e-05	0.000473	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.96e-05	0.00047	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	3.96e-05	0.000469	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	3.95e-05	0.000469	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.92e-05	0.000465	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.86e-05	0.000458	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.77e-05	0.000448	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	3.73e-05	0.000443	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	3.72e-05	0.000441	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.7e-05	0.000439	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.65e-05	0.000433	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.64e-05	0.000432	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.63e-05	0.000431	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.6e-05	0.000428	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.55e-05	0.000421	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TYMP—urinary bladder cancer	3.54e-05	0.00042	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.47e-05	0.000412	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.4e-05	0.000403	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RBX1—urinary bladder cancer	3.4e-05	0.000403	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.38e-05	0.000401	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	3.36e-05	0.000399	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.35e-05	0.000397	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.31e-05	0.000392	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NAT2—urinary bladder cancer	3.2e-05	0.00038	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TSC1—urinary bladder cancer	3.2e-05	0.000379	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.16e-05	0.000375	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.14e-05	0.000372	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.14e-05	0.000372	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.08e-05	0.000366	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.08e-05	0.000365	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JAG1—urinary bladder cancer	3.04e-05	0.000361	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.03e-05	0.000359	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.96e-05	0.000351	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TYMP—urinary bladder cancer	2.91e-05	0.000345	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.89e-05	0.000343	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.88e-05	0.000342	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.87e-05	0.00034	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.82e-05	0.000334	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.8e-05	0.000332	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.79e-05	0.000331	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.77e-05	0.000328	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.76e-05	0.000328	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.63e-05	0.000312	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.61e-05	0.000309	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.58e-05	0.000306	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—RHOA—urinary bladder cancer	2.57e-05	0.000305	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.56e-05	0.000304	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.56e-05	0.000304	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.54e-05	0.000302	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.49e-05	0.000295	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.48e-05	0.000294	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.47e-05	0.000293	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—S100B—urinary bladder cancer	2.46e-05	0.000292	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.46e-05	0.000292	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.44e-05	0.00029	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.44e-05	0.000289	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.41e-05	0.000286	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.38e-05	0.000282	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.36e-05	0.000281	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—RHOA—urinary bladder cancer	2.34e-05	0.000277	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.27e-05	0.000269	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.26e-05	0.000268	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.25e-05	0.000267	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.23e-05	0.000265	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.23e-05	0.000265	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.23e-05	0.000264	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NCOR1—urinary bladder cancer	2.22e-05	0.000263	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.16e-05	0.000257	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—IL2—urinary bladder cancer	2.16e-05	0.000256	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.1e-05	0.000249	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.1e-05	0.000249	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.08e-05	0.000247	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.08e-05	0.000247	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.07e-05	0.000246	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.06e-05	0.000245	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.05e-05	0.000243	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.04e-05	0.000242	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.02e-05	0.00024	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.02e-05	0.00024	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2e-05	0.000237	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.99e-05	0.000236	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—urinary bladder cancer	1.96e-05	0.000233	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TERT—urinary bladder cancer	1.95e-05	0.000232	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.92e-05	0.000228	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.9e-05	0.000225	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.8e-05	0.000213	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGFR3—urinary bladder cancer	1.79e-05	0.000213	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.78e-05	0.000211	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.78e-05	0.000211	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.77e-05	0.00021	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.75e-05	0.000207	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ESR1—urinary bladder cancer	1.74e-05	0.000206	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.73e-05	0.000205	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.72e-05	0.000204	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.72e-05	0.000204	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.7e-05	0.000202	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.69e-05	0.000201	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.68e-05	0.000199	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.66e-05	0.000197	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.63e-05	0.000193	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.6e-05	0.00019	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.58e-05	0.000188	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.58e-05	0.000188	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CREBBP—urinary bladder cancer	1.53e-05	0.000181	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.51e-05	0.00018	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—urinary bladder cancer	1.51e-05	0.000179	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.5e-05	0.000178	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—urinary bladder cancer	1.5e-05	0.000178	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.49e-05	0.000176	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.48e-05	0.000176	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.43e-05	0.00017	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.42e-05	0.000169	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—KRAS—urinary bladder cancer	1.42e-05	0.000168	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.41e-05	0.000168	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.4e-05	0.000166	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.4e-05	0.000166	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.39e-05	0.000165	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.39e-05	0.000165	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RHOA—urinary bladder cancer	1.38e-05	0.000164	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.38e-05	0.000163	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.38e-05	0.000163	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.37e-05	0.000163	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.37e-05	0.000163	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.35e-05	0.000161	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.33e-05	0.000158	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.32e-05	0.000156	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.31e-05	0.000156	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.3e-05	0.000154	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.3e-05	0.000154	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.3e-05	0.000154	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.29e-05	0.000154	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.29e-05	0.000153	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.29e-05	0.000153	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB2—urinary bladder cancer	1.28e-05	0.000152	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.24e-05	0.000147	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.23e-05	0.000146	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.22e-05	0.000145	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	0.000144	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.21e-05	0.000144	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL8—urinary bladder cancer	1.21e-05	0.000144	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.21e-05	0.000144	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HRAS—urinary bladder cancer	1.2e-05	0.000143	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.2e-05	0.000142	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.16e-05	0.000137	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—urinary bladder cancer	1.16e-05	0.000137	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	0.000136	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.14e-05	0.000135	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.13e-05	0.000134	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—urinary bladder cancer	1.13e-05	0.000134	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.11e-05	0.000132	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.11e-05	0.000131	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.1e-05	0.00013	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.1e-05	0.00013	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—urinary bladder cancer	1.1e-05	0.00013	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.09e-05	0.00013	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTEN—urinary bladder cancer	1.09e-05	0.000129	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.09e-05	0.000129	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.05e-05	0.000125	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EP300—urinary bladder cancer	1.04e-05	0.000123	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.03e-05	0.000123	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SRC—urinary bladder cancer	1.01e-05	0.00012	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARG—urinary bladder cancer	9.87e-06	0.000117	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	9.72e-06	0.000115	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	9.48e-06	0.000113	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	9.3e-06	0.00011	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	9.23e-06	0.00011	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	9.22e-06	0.000109	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—urinary bladder cancer	9.05e-06	0.000107	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	8.94e-06	0.000106	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	8.91e-06	0.000106	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	8.86e-06	0.000105	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—urinary bladder cancer	8.85e-06	0.000105	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.58e-06	0.000102	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.49e-06	0.000101	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.49e-06	0.000101	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KRAS—urinary bladder cancer	8.36e-06	9.92e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	8.13e-06	9.64e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.98e-06	9.47e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARG—urinary bladder cancer	7.88e-06	9.35e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	7.77e-06	9.22e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.76e-06	9.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	7.57e-06	8.98e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.5e-06	8.9e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—urinary bladder cancer	7.43e-06	8.82e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—EP300—urinary bladder cancer	7.41e-06	8.8e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	7.32e-06	8.68e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	7.25e-06	8.61e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HRAS—urinary bladder cancer	7.11e-06	8.44e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.77e-06	8.03e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—EP300—urinary bladder cancer	6.46e-06	7.66e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.38e-06	7.57e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.33e-06	7.51e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.2e-06	7.35e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—EP300—urinary bladder cancer	6.09e-06	7.22e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.08e-06	7.22e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—EP300—urinary bladder cancer	6.03e-06	7.16e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.84e-06	6.93e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTEN—urinary bladder cancer	5.41e-06	6.41e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.16e-06	6.12e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.78e-06	5.68e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.17e-06	4.95e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.98e-06	4.72e-05	CbGpPWpGaD
